Central Garden & Pet Company Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Consolidating Condensed Statement of Cash Flows Based on Company's Understanding of SEC's Interpretation (Detail)

Consolidating Condensed Statement of Cash Flows Based on Company's Understanding of SEC's Interpretation (Detail) (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Mar. 28, 2015	Mar. 29, 2014
Condensed Financial Statements, Captions [Line Items]
Net cash (used) provided by operating activities	$ (98,521)	$ (60,043)
Additions to property, plant and equipment	(11,025)	(10,024)
Payments to acquire companies, net of cash acquired	(16,000)	0
Proceeds from short term investments	9,997	3,600
Investment in short term investments	(17)	0
Change in restricted cash	1,700	0
Other investing activities	(331)	0
Intercompany investing activities	0	0
Net cash (used) provided by investing activities	(15,676)	(6,424)
Repayments of long-term debt	(50,141)us-gaap_RepaymentsOfLongTermDebt	(203)us-gaap_RepaymentsOfLongTermDebt
Borrowings under revolving line of credit	186,000us-gaap_ProceedsFromLinesOfCredit	188,000us-gaap_ProceedsFromLinesOfCredit
Repayments on revolving line of credit	(71,000)us-gaap_RepaymentsOfLinesOfCredit	(116,000)us-gaap_RepaymentsOfLinesOfCredit
Proceeds from issuance of common stock	1,220	461
Repurchase of common stock	(17,164)	(924)
Distribution to noncontrolling interest	(1,680)	(633)
Payment of deferred financing costs	0us-gaap_PaymentsOfFinancingCosts	(3,087)us-gaap_PaymentsOfFinancingCosts
Excess tax benefits from stock-based awards	351	321
Distribution to parent	0us-gaap_PaymentsOfCapitalDistribution	0us-gaap_PaymentsOfCapitalDistribution
Intercompany financing activities	0	0
Net cash (used) provided by financing activities	47,586	67,935
Effect of exchange rates on cash	(122)	124
Net decrease in cash and cash equivalents	(66,733)	1,592
Cash and equivalents at beginning of period	78,676	15,156
Cash and equivalents at end of period	11,943	16,748
Parent [Member]
Condensed Financial Statements, Captions [Line Items]
Net cash (used) provided by operating activities	(36,828)	(35,501)
Additions to property, plant and equipment	(1,359)	(4,507)
Payments to acquire companies, net of cash acquired	(16,000)
Proceeds from short term investments	9,997	3,600
Investment in short term investments	(17)
Change in restricted cash	1,700
Other investing activities	(331)
Intercompany investing activities	(27,949)	(31,360)
Net cash (used) provided by investing activities	(33,959)	(32,267)
Repayments of long-term debt	(50,131)	(104)
Borrowings under revolving line of credit	186,000	188,000
Repayments on revolving line of credit	(71,000)	(116,000)
Proceeds from issuance of common stock	1,220	461
Repurchase of common stock	(17,164)	(924)
Distribution to noncontrolling interest	0	0
Payment of deferred financing costs		(3,087)
Excess tax benefits from stock-based awards	351	321
Distribution to parent	0	0
Intercompany financing activities	(34,891)	1,376
Net cash (used) provided by financing activities	14,385	70,043
Effect of exchange rates on cash	(910)	288
Net decrease in cash and cash equivalents	(57,312)	2,563
Cash and equivalents at beginning of period	63,471	5,438
Cash and equivalents at end of period	6,159	8,001
Non-Guarantor Subsidiaries [Member]
Condensed Financial Statements, Captions [Line Items]
Net cash (used) provided by operating activities	(5,623)	604
Additions to property, plant and equipment	(154)	(473)
Payments to acquire companies, net of cash acquired	0
Proceeds from short term investments	0	0
Investment in short term investments	0
Change in restricted cash	0
Other investing activities	0
Intercompany investing activities	0	0
Net cash (used) provided by investing activities	(154)	(473)
Repayments of long-term debt	0	0
Borrowings under revolving line of credit	0	0
Repayments on revolving line of credit	0	0
Proceeds from issuance of common stock	0	0
Repurchase of common stock	0	0
Distribution to noncontrolling interest	(1,680)	(633)
Payment of deferred financing costs		0
Excess tax benefits from stock-based awards	0	0
Distribution to parent	(6,719)	(2,534)
Intercompany financing activities	5,102	2,941
Net cash (used) provided by financing activities	(3,297)	(226)
Effect of exchange rates on cash	577	(89)
Net decrease in cash and cash equivalents	(8,497)	(184)
Cash and equivalents at beginning of period	12,806	7,003
Cash and equivalents at end of period	4,309	6,819
Guarantor Subsidiaries [Member]
Condensed Financial Statements, Captions [Line Items]
Net cash (used) provided by operating activities	(49,351)	(22,612)
Additions to property, plant and equipment	(9,512)	(5,044)
Payments to acquire companies, net of cash acquired	0
Proceeds from short term investments	0	0
Investment in short term investments	0
Change in restricted cash	0
Other investing activities	0
Intercompany investing activities	57,738	27,043
Net cash (used) provided by investing activities	48,226	21,999
Repayments of long-term debt	(10)	(99)
Borrowings under revolving line of credit	0	0
Repayments on revolving line of credit	0	0
Proceeds from issuance of common stock	0	0
Repurchase of common stock	0	0
Distribution to noncontrolling interest	0	0
Payment of deferred financing costs		0
Excess tax benefits from stock-based awards	0	0
Distribution to parent	0	0
Intercompany financing activities	0	0
Net cash (used) provided by financing activities	(10)	(99)
Effect of exchange rates on cash	211	(75)
Net decrease in cash and cash equivalents	(924)	(787)
Cash and equivalents at beginning of period	2,399	2,715
Cash and equivalents at end of period	1,475	1,928
Eliminations [Member]
Condensed Financial Statements, Captions [Line Items]
Net cash (used) provided by operating activities	(6,719)	(2,534)
Additions to property, plant and equipment	0	0
Payments to acquire companies, net of cash acquired	0
Proceeds from short term investments	0	0
Investment in short term investments	0
Change in restricted cash	0
Other investing activities	0
Intercompany investing activities	(29,789)	4,317
Net cash (used) provided by investing activities	(29,789)	4,317
Repayments of long-term debt	0	0
Borrowings under revolving line of credit	0	0
Repayments on revolving line of credit	0	0
Proceeds from issuance of common stock	0	0
Repurchase of common stock	0	0
Distribution to noncontrolling interest	0	0
Payment of deferred financing costs		0
Excess tax benefits from stock-based awards	0	0
Distribution to parent	6,719	2,534
Intercompany financing activities	29,789	(4,317)
Net cash (used) provided by financing activities	36,508	(1,783)
Effect of exchange rates on cash	0	0
Net decrease in cash and cash equivalents	0	0
Cash and equivalents at beginning of period	0	0
Cash and equivalents at end of period	$ 0	$ 0